Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

Matthew T Roe, Paul W Armstrong, Keith A A Fox, Harvey D White, Dorairaj Prabhakaran, Shaun G Goodman, Jan H Cornel, Deepak L Bhatt, Peter Clemmensen, Felipe Martinez, Diego Ardissino, Jose C Nicolau, William E Boden, Paul A Gurbel, Witold Ruzyllo, Anthony J Dalby, Darren K McGuire, Jose L Leiva-Pons, Alexander Parkhomenko, Shmuel GottliebGracita O Topacio, Christian Hamm, Gregory Pavlides, Assen R Goudev, Ali Oto, Chuen-Den Tseng, Bela Merkely, Vladimir Gasparovic, Ramon Corbalan, Mircea Cinteză, R Craig McLendon, Kenneth J Winters, Eileen B Brown, Yuliya Lokhnygina, Philip E Aylward, Kurt Huber, Judith S Hochman, E Magnus Ohman, TRILOGY ACS Investigators

    746 Citations (Scopus)

    Abstract

    The effect of intensified platelet inhibition for patients with unstable angina or myocardial infarction without ST-segment elevation who do not undergo revascularization has not been delineated.
    Original languageEnglish
    JournalNew England Journal of Medicine
    Volume367
    Issue number14
    Pages (from-to)1297-309
    Number of pages13
    ISSN0028-4793
    DOIs
    Publication statusPublished - 2012

    Keywords

    • Acute Coronary Syndrome
    • Aged
    • Angina, Unstable
    • Aspirin
    • Cardiovascular Diseases
    • Double-Blind Method
    • Drug Therapy, Combination
    • Female
    • Follow-Up Studies
    • Humans
    • Kaplan-Meier Estimate
    • Male
    • Middle Aged
    • Myocardial Infarction
    • Piperazines
    • Platelet Aggregation Inhibitors
    • Purinergic P2 Receptor Antagonists
    • Stroke
    • Thiophenes
    • Ticlopidine

    Fingerprint

    Dive into the research topics of 'Prasugrel versus clopidogrel for acute coronary syndromes without revascularization'. Together they form a unique fingerprint.

    Cite this